FDA Drug recall D-0138-2026
Espumil, Lipophilic foam base, 500 ml, 24G15-T02-115604
- FDA Drug
- Class III
- ongoing
- Published 2025-11-05
On 2025-11-05 the FDA classified a Class III recall of Espumil, Lipophilic foam base, 500 ml, 24G15-T02-115604 by Letco Medical, citing labeling: Not Elsewhere Classified.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0138-2026 |
| Classification | Class III |
| Status | ongoing |
| Initiated | 2025-09-12 |
| Published | 2025-11-05 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | Letco Medical |
| Distribution | AL |
Product
Espumil, Lipophilic foam base, 500 ml, 24G15-T02-115604
Reason
Labeling: Not Elsewhere Classified
Identifiers
| code_info | Batch # 24G15-T02-115604, exp. 11/30/2026 |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: ongoing.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0138-2026%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.